https://www.selleckchem.com/pr....oducts/debio-0123.ht
bulk drug substance. Further development of the AS03-adjuvanted candidate vaccine will focus on identifying the optimal antigen formulation and dose. Sanofi Pasteur and Biomedical Advanced Research and Development Authority. Sanofi Pasteur and Biomedical Advanced Research and Development Authority. Given the scale of the ongoing COVID-19 pandemic, the development of vaccines based on different platforms is essential, particularly in light of emerging viral variants, the absence of information on vaccine-induced immune durability, and
Like
Comment
Share
